English
简体中文
Total: £ 56.28
Published Date: 2026-03-02 | Pages: 116 | Tables: 117 | Medical Care
The global Mouse Model for Drug Screening and Evaluation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Mouse Model for Drug Screening and Evaluation competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The drug screening and evaluation mouse model is an experimental mouse model used to evaluate the efficacy and safety of candidate drugs. Through gene editing or other biotechnologies, these mice are designed or modified to simulate specific human diseases or pathological conditions, and are used to screen and test the effectiveness, toxicity and side effects of drugs during the drug development process. The drug screening and evaluation mouse model provides a biologically relevant system for drug development, which helps to predict the potential effects of drugs in humans in advance and optimize the drug development process.
The North American market for Mouse Model for Drug Screening and Evaluation is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Mouse Model for Drug Screening and Evaluation is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Mouse Model for Drug Screening and Evaluation include ingenious targeting laboratory, The Jackson Laboratory, Charles River, Taconic Biosciences, Cavens, Beijing Vitalstar Biotechnology, Model Organisms Center, GENET-MED, Cyagen, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Mouse Model for Drug Screening and Evaluation market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mouse Model for Drug Screening and Evaluation. The Mouse Model for Drug Screening and Evaluation market size, estimates, and forecasts are provided in terms of sales volume (Unit) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Mouse Model for Drug Screening and Evaluation market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mouse Model for Drug Screening and Evaluation manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
ingenious targeting laboratory
The Jackson Laboratory
Charles River
Taconic Biosciences
Cavens
Beijing Vitalstar Biotechnology
Model Organisms Center
GENET-MED
Cyagen
Segment by Type
Tumor Model
Nervous System Model
Immunodeficiency
Metabolic and Cardiovascular Disease Model
Digestive System Model
Others
by Application
Research Laboratories
Pharmaceutical Companies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Mouse Model for Drug Screening and Evaluation manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Mouse Model for Drug Screening and Evaluation sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Mouse Model for Drug Screening and Evaluation Market Overview
1.1 Product Definition
1.2 Mouse Model for Drug Screening and Evaluation by Type
1.2.1 Global Mouse Model for Drug Screening and Evaluation Market Value by Type: 2025 vs 2032
1.2.2 Tumor Model
1.2.3 Nervous System Model
1.2.4 Immunodeficiency
1.2.5 Metabolic and Cardiovascular Disease Model
1.2.6 Digestive System Model
1.2.7 Others
1.3 Mouse Model for Drug Screening and Evaluation by Application
1.3.1 Global Mouse Model for Drug Screening and Evaluation Market Value by Application: 2025 vs 2032
1.3.2 Research Laboratories
1.3.3 Pharmaceutical Companies
1.3.4 Other
1.4 Global Mouse Model for Drug Screening and Evaluation Market Size Estimates and Forecasts
1.4.1 Global Mouse Model for Drug Screening and Evaluation Revenue 2021–2032
1.4.2 Global Mouse Model for Drug Screening and Evaluation Sales 2021–2032
1.4.3 Global Mouse Model for Drug Screening and Evaluation Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Mouse Model for Drug Screening and Evaluation Market Competition by Manufacturers
2.1 Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mouse Model for Drug Screening and Evaluation Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mouse Model for Drug Screening and Evaluation, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mouse Model for Drug Screening and Evaluation, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mouse Model for Drug Screening and Evaluation, Product Types and Applications
2.7 Global Key Manufacturers of Mouse Model for Drug Screening and Evaluation, Date of Entry into the Industry
2.8 Global Mouse Model for Drug Screening and Evaluation Market Competitive Situation and Trends
2.8.1 Global Mouse Model for Drug Screening and Evaluation Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mouse Model for Drug Screening and Evaluation Players Market Share by Revenue
2.8.3 Global Mouse Model for Drug Screening and Evaluation Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mouse Model for Drug Screening and Evaluation Market Scenario by Region
3.1 Global Mouse Model for Drug Screening and Evaluation Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mouse Model for Drug Screening and Evaluation Sales by Region: 2021–2032
3.2.1 Global Mouse Model for Drug Screening and Evaluation Sales by Region: 2021–2026
3.2.2 Global Mouse Model for Drug Screening and Evaluation Sales by Region: 2027–2032
3.3 Global Mouse Model for Drug Screening and Evaluation Revenue by Region: 2021–2032
3.3.1 Global Mouse Model for Drug Screening and Evaluation Revenue by Region: 2021–2026
3.3.2 Global Mouse Model for Drug Screening and Evaluation Revenue by Region: 2027–2032
3.4 North America Mouse Model for Drug Screening and Evaluation Market Facts & Figures by Country
3.4.1 North America Mouse Model for Drug Screening and Evaluation Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mouse Model for Drug Screening and Evaluation Sales by Country (2021–2032)
3.4.3 North America Mouse Model for Drug Screening and Evaluation Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mouse Model for Drug Screening and Evaluation Market Facts & Figures by Country
3.5.1 Europe Mouse Model for Drug Screening and Evaluation Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mouse Model for Drug Screening and Evaluation Sales by Country (2021–2032)
3.5.3 Europe Mouse Model for Drug Screening and Evaluation Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mouse Model for Drug Screening and Evaluation Market Facts & Figures by Region
3.6.1 Asia Pacific Mouse Model for Drug Screening and Evaluation Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mouse Model for Drug Screening and Evaluation Sales by Region (2021–2032)
3.6.3 Asia Pacific Mouse Model for Drug Screening and Evaluation Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mouse Model for Drug Screening and Evaluation Market Facts & Figures by Country
3.7.1 Latin America Mouse Model for Drug Screening and Evaluation Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mouse Model for Drug Screening and Evaluation Sales by Country (2021–2032)
3.7.3 Latin America Mouse Model for Drug Screening and Evaluation Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mouse Model for Drug Screening and Evaluation Market Facts & Figures by Country
3.8.1 Middle East and Africa Mouse Model for Drug Screening and Evaluation Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mouse Model for Drug Screening and Evaluation Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mouse Model for Drug Screening and Evaluation Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mouse Model for Drug Screening and Evaluation Sales by Type (2021–2032)
4.1.1 Global Mouse Model for Drug Screening and Evaluation Sales by Type (2021–2026)
4.1.2 Global Mouse Model for Drug Screening and Evaluation Sales by Type (2027–2032)
4.1.3 Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Type (2021–2032)
4.2 Global Mouse Model for Drug Screening and Evaluation Revenue by Type (2021–2032)
4.2.1 Global Mouse Model for Drug Screening and Evaluation Revenue by Type (2021–2026)
4.2.2 Global Mouse Model for Drug Screening and Evaluation Revenue by Type (2027–2032)
4.2.3 Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Type (2021–2032)
4.3 Global Mouse Model for Drug Screening and Evaluation Price by Type (2021–2032)
5 Segment by Application
5.1 Global Mouse Model for Drug Screening and Evaluation Sales by Application (2021–2032)
5.1.1 Global Mouse Model for Drug Screening and Evaluation Sales by Application (2021–2026)
5.1.2 Global Mouse Model for Drug Screening and Evaluation Sales by Application (2027–2032)
5.1.3 Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Application (2021–2032)
5.2 Global Mouse Model for Drug Screening and Evaluation Revenue by Application (2021–2032)
5.2.1 Global Mouse Model for Drug Screening and Evaluation Revenue by Application (2021–2026)
5.2.2 Global Mouse Model for Drug Screening and Evaluation Revenue by Application (2027–2032)
5.2.3 Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Application (2021–2032)
5.3 Global Mouse Model for Drug Screening and Evaluation Price by Application (2021–2032)
6 Key Companies Profiled
6.1 ingenious targeting laboratory
6.1.1 ingenious targeting laboratory Company Information
6.1.2 ingenious targeting laboratory Description and Business Overview
6.1.3 ingenious targeting laboratory Mouse Model for Drug Screening and Evaluation Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 ingenious targeting laboratory Mouse Model for Drug Screening and Evaluation Product Portfolio
6.1.5 ingenious targeting laboratory Recent Developments/Updates
6.2 The Jackson Laboratory
6.2.1 The Jackson Laboratory Company Information
6.2.2 The Jackson Laboratory Description and Business Overview
6.2.3 The Jackson Laboratory Mouse Model for Drug Screening and Evaluation Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 The Jackson Laboratory Mouse Model for Drug Screening and Evaluation Product Portfolio
6.2.5 The Jackson Laboratory Recent Developments/Updates
6.3 Charles River
6.3.1 Charles River Company Information
6.3.2 Charles River Description and Business Overview
6.3.3 Charles River Mouse Model for Drug Screening and Evaluation Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Charles River Mouse Model for Drug Screening and Evaluation Product Portfolio
6.3.5 Charles River Recent Developments/Updates
6.4 Taconic Biosciences
6.4.1 Taconic Biosciences Company Information
6.4.2 Taconic Biosciences Description and Business Overview
6.4.3 Taconic Biosciences Mouse Model for Drug Screening and Evaluation Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Taconic Biosciences Mouse Model for Drug Screening and Evaluation Product Portfolio
6.4.5 Taconic Biosciences Recent Developments/Updates
6.5 Cavens
6.5.1 Cavens Company Information
6.5.2 Cavens Description and Business Overview
6.5.3 Cavens Mouse Model for Drug Screening and Evaluation Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cavens Mouse Model for Drug Screening and Evaluation Product Portfolio
6.5.5 Cavens Recent Developments/Updates
6.6 Beijing Vitalstar Biotechnology
6.6.1 Beijing Vitalstar Biotechnology Company Information
6.6.2 Beijing Vitalstar Biotechnology Description and Business Overview
6.6.3 Beijing Vitalstar Biotechnology Mouse Model for Drug Screening and Evaluation Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Beijing Vitalstar Biotechnology Mouse Model for Drug Screening and Evaluation Product Portfolio
6.6.5 Beijing Vitalstar Biotechnology Recent Developments/Updates
6.7 Model Organisms Center
6.7.1 Model Organisms Center Company Information
6.7.2 Model Organisms Center Description and Business Overview
6.7.3 Model Organisms Center Mouse Model for Drug Screening and Evaluation Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Model Organisms Center Mouse Model for Drug Screening and Evaluation Product Portfolio
6.7.5 Model Organisms Center Recent Developments/Updates
6.8 GENET-MED
6.8.1 GENET-MED Company Information
6.8.2 GENET-MED Description and Business Overview
6.8.3 GENET-MED Mouse Model for Drug Screening and Evaluation Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 GENET-MED Mouse Model for Drug Screening and Evaluation Product Portfolio
6.8.5 GENET-MED Recent Developments/Updates
6.9 Cyagen
6.9.1 Cyagen Company Information
6.9.2 Cyagen Description and Business Overview
6.9.3 Cyagen Mouse Model for Drug Screening and Evaluation Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cyagen Mouse Model for Drug Screening and Evaluation Product Portfolio
6.9.5 Cyagen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mouse Model for Drug Screening and Evaluation Industry Chain Analysis
7.2 Mouse Model for Drug Screening and Evaluation Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mouse Model for Drug Screening and Evaluation Production Mode & Process Analysis
7.4 Mouse Model for Drug Screening and Evaluation Sales and Marketing
7.4.1 Mouse Model for Drug Screening and Evaluation Sales Channels
7.4.2 Mouse Model for Drug Screening and Evaluation Distributors
7.5 Mouse Model for Drug Screening and Evaluation Customer Analysis
8 Mouse Model for Drug Screening and Evaluation Market Dynamics
8.1 Mouse Model for Drug Screening and Evaluation Industry Trends
8.2 Mouse Model for Drug Screening and Evaluation Market Drivers
8.3 Mouse Model for Drug Screening and Evaluation Market Challenges
8.4 Mouse Model for Drug Screening and Evaluation Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Mouse Model for Drug Screening and Evaluation Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Mouse Model for Drug Screening and Evaluation Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Mouse Model for Drug Screening and Evaluation Market Competitive Situation by Manufacturers in 2025
Table 4. Global Mouse Model for Drug Screening and Evaluation Sales (Unit) of Key Manufacturers (2021–2026)
Table 5. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Mouse Model for Drug Screening and Evaluation Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Mouse Model for Drug Screening and Evaluation Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Mouse Model for Drug Screening and Evaluation Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Mouse Model for Drug Screening and Evaluation, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Mouse Model for Drug Screening and Evaluation, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Mouse Model for Drug Screening and Evaluation, Product Types and Applications
Table 12. Global Key Manufacturers of Mouse Model for Drug Screening and Evaluation, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mouse Model for Drug Screening and Evaluation Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mouse Model for Drug Screening and Evaluation Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mouse Model for Drug Screening and Evaluation Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Mouse Model for Drug Screening and Evaluation Sales by Region (Unit), 2021–2026
Table 18. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Region (2021–2026)
Table 19. Global Mouse Model for Drug Screening and Evaluation Sales by Region (Unit), 2027–2032
Table 20. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Region (2027–2032)
Table 21. Global Mouse Model for Drug Screening and Evaluation Revenue by Region (US$ Million), 2021–2026
Table 22. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Region (2021–2026)
Table 23. Global Mouse Model for Drug Screening and Evaluation Revenue by Region (US$ Million), 2027–2032
Table 24. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Region (2027–2032)
Table 25. North America Mouse Model for Drug Screening and Evaluation Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Mouse Model for Drug Screening and Evaluation Sales by Country (Unit), 2021–2026
Table 27. North America Mouse Model for Drug Screening and Evaluation Sales by Country (Unit), 2027–2032
Table 28. North America Mouse Model for Drug Screening and Evaluation Revenue by Country (US$ Million), 2021–2026
Table 29. North America Mouse Model for Drug Screening and Evaluation Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Mouse Model for Drug Screening and Evaluation Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Mouse Model for Drug Screening and Evaluation Sales by Country (Unit), 2021–2026
Table 32. Europe Mouse Model for Drug Screening and Evaluation Sales by Country (Unit), 2027–2032
Table 33. Europe Mouse Model for Drug Screening and Evaluation Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Mouse Model for Drug Screening and Evaluation Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Mouse Model for Drug Screening and Evaluation Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Mouse Model for Drug Screening and Evaluation Sales by Region (Unit), 2021–2026
Table 37. Asia Pacific Mouse Model for Drug Screening and Evaluation Sales by Region (Unit), 2027–2032
Table 38. Asia Pacific Mouse Model for Drug Screening and Evaluation Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Mouse Model for Drug Screening and Evaluation Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Mouse Model for Drug Screening and Evaluation Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Mouse Model for Drug Screening and Evaluation Sales by Country (Unit), 2021–2026
Table 42. Latin America Mouse Model for Drug Screening and Evaluation Sales by Country (Unit), 2027–2032
Table 43. Latin America Mouse Model for Drug Screening and Evaluation Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Mouse Model for Drug Screening and Evaluation Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Mouse Model for Drug Screening and Evaluation Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Mouse Model for Drug Screening and Evaluation Sales by Country (Unit), 2021–2026
Table 47. Middle East and Africa Mouse Model for Drug Screening and Evaluation Sales by Country (Unit), 2027–2032
Table 48. Middle East and Africa Mouse Model for Drug Screening and Evaluation Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Mouse Model for Drug Screening and Evaluation Revenue by Country (US$ Million), 2027–2032
Table 50. Global Mouse Model for Drug Screening and Evaluation Sales (Unit) by Type (2021–2026)
Table 51. Global Mouse Model for Drug Screening and Evaluation Sales (Unit) by Type (2027–2032)
Table 52. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Type (2021–2026)
Table 53. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Type (2027–2032)
Table 54. Global Mouse Model for Drug Screening and Evaluation Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Mouse Model for Drug Screening and Evaluation Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Type (2021–2026)
Table 57. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Type (2027–2032)
Table 58. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Type (2021–2026)
Table 59. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Type (2027–2032)
Table 60. Global Mouse Model for Drug Screening and Evaluation Sales (Unit) by Application (2021–2026)
Table 61. Global Mouse Model for Drug Screening and Evaluation Sales (Unit) by Application (2027–2032)
Table 62. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Application (2021–2026)
Table 63. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Application (2027–2032)
Table 64. Global Mouse Model for Drug Screening and Evaluation Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Mouse Model for Drug Screening and Evaluation Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Application (2021–2026)
Table 67. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Application (2027–2032)
Table 68. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Application (2021–2026)
Table 69. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Application (2027–2032)
Table 70. ingenious targeting laboratory Company Information
Table 71. ingenious targeting laboratory Description and Business Overview
Table 72. ingenious targeting laboratory Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. ingenious targeting laboratory Mouse Model for Drug Screening and Evaluation Product
Table 74. ingenious targeting laboratory Recent Developments/Updates
Table 75. The Jackson Laboratory Company Information
Table 76. The Jackson Laboratory Description and Business Overview
Table 77. The Jackson Laboratory Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. The Jackson Laboratory Mouse Model for Drug Screening and Evaluation Product
Table 79. The Jackson Laboratory Recent Developments/Updates
Table 80. Charles River Company Information
Table 81. Charles River Description and Business Overview
Table 82. Charles River Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Charles River Mouse Model for Drug Screening and Evaluation Product
Table 84. Charles River Recent Developments/Updates
Table 85. Taconic Biosciences Company Information
Table 86. Taconic Biosciences Description and Business Overview
Table 87. Taconic Biosciences Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. Taconic Biosciences Mouse Model for Drug Screening and Evaluation Product
Table 89. Taconic Biosciences Recent Developments/Updates
Table 90. Cavens Company Information
Table 91. Cavens Description and Business Overview
Table 92. Cavens Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Cavens Mouse Model for Drug Screening and Evaluation Product
Table 94. Cavens Recent Developments/Updates
Table 95. Beijing Vitalstar Biotechnology Company Information
Table 96. Beijing Vitalstar Biotechnology Description and Business Overview
Table 97. Beijing Vitalstar Biotechnology Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. Beijing Vitalstar Biotechnology Mouse Model for Drug Screening and Evaluation Product
Table 99. Beijing Vitalstar Biotechnology Recent Developments/Updates
Table 100. Model Organisms Center Company Information
Table 101. Model Organisms Center Description and Business Overview
Table 102. Model Organisms Center Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Model Organisms Center Mouse Model for Drug Screening and Evaluation Product
Table 104. Model Organisms Center Recent Developments/Updates
Table 105. GENET-MED Company Information
Table 106. GENET-MED Description and Business Overview
Table 107. GENET-MED Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. GENET-MED Mouse Model for Drug Screening and Evaluation Product
Table 109. GENET-MED Recent Developments/Updates
Table 110. Cyagen Company Information
Table 111. Cyagen Description and Business Overview
Table 112. Cyagen Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Cyagen Mouse Model for Drug Screening and Evaluation Product
Table 114. Cyagen Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Mouse Model for Drug Screening and Evaluation Distributors List
Table 118. Mouse Model for Drug Screening and Evaluation Customers List
Table 119. Mouse Model for Drug Screening and Evaluation Market Trends
Table 120. Mouse Model for Drug Screening and Evaluation Market Drivers
Table 121. Mouse Model for Drug Screening and Evaluation Market Challenges
Table 122. Mouse Model for Drug Screening and Evaluation Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mouse Model for Drug Screening and Evaluation
Figure 2. Global Mouse Model for Drug Screening and Evaluation Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Mouse Model for Drug Screening and Evaluation Market Share by Type: 2025 & 2032
Figure 4. Tumor Model Product Picture
Figure 5. Nervous System Model Product Picture
Figure 6. Immunodeficiency Product Picture
Figure 7. Metabolic and Cardiovascular Disease Model Product Picture
Figure 8. Digestive System Model Product Picture
Figure 9. Others Product Picture
Figure 10. Global Mouse Model for Drug Screening and Evaluation Market Value by Application (US$ Million), 2021–2032
Figure 11. Global Mouse Model for Drug Screening and Evaluation Market Share by Application: 2025 & 2032
Figure 12. Research Laboratories
Figure 13. Pharmaceutical Companies
Figure 14. Other
Figure 15. Global Mouse Model for Drug Screening and Evaluation Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Mouse Model for Drug Screening and Evaluation Market Size (US$ Million), 2021–2032
Figure 17. Global Mouse Model for Drug Screening and Evaluation Sales (Unit), 2021–2032
Figure 18. Global Mouse Model for Drug Screening and Evaluation Average Price (USD/Unit), 2021–2032
Figure 19. Mouse Model for Drug Screening and Evaluation Report Years Considered
Figure 20. Mouse Model for Drug Screening and Evaluation Sales Share by Manufacturers in 2025
Figure 21. Global Mouse Model for Drug Screening and Evaluation Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Mouse Model for Drug Screening and Evaluation Players: Market Share by Revenue in Mouse Model for Drug Screening and Evaluation in 2025
Figure 23. Mouse Model for Drug Screening and Evaluation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Mouse Model for Drug Screening and Evaluation Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Mouse Model for Drug Screening and Evaluation Sales Market Share by Country (2021–2032)
Figure 26. North America Mouse Model for Drug Screening and Evaluation Revenue Market Share by Country (2021–2032)
Figure 27. United States Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Mouse Model for Drug Screening and Evaluation Sales Market Share by Country (2021–2032)
Figure 30. Europe Mouse Model for Drug Screening and Evaluation Revenue Market Share by Country (2021–2032)
Figure 31. Germany Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Mouse Model for Drug Screening and Evaluation Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Mouse Model for Drug Screening and Evaluation Revenue Market Share by Region (2021–2032)
Figure 38. China Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Mouse Model for Drug Screening and Evaluation Sales Market Share by Country (2021–2032)
Figure 46. Latin America Mouse Model for Drug Screening and Evaluation Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Mouse Model for Drug Screening and Evaluation Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Mouse Model for Drug Screening and Evaluation Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Mouse Model for Drug Screening and Evaluation by Type (2021–2032)
Figure 57. Global Revenue Market Share of Mouse Model for Drug Screening and Evaluation by Type (2021–2032)
Figure 58. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of Mouse Model for Drug Screening and Evaluation by Application (2021–2032)
Figure 60. Global Revenue Market Share of Mouse Model for Drug Screening and Evaluation by Application (2021–2032)
Figure 61. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Application (2021–2032)
Figure 62. Mouse Model for Drug Screening and Evaluation Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
